dievini Hopp Biotech Holding logo

dievini Hopp Biotech Holding

Europe, Baden-Wurttemberg, Germany, Walldorf

Description

dievini Hopp Biotech Holding is a German company dedicated to the support and coaching of life and health sciences companies.

Investor Profile

dievini Hopp Biotech Holding has backed more than 19 startups, with 0 new investments in the last 12 months alone. The firm has led 13 rounds, about 68% of its total and boasts 4 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series D, Series C, Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in Germany, Switzerland.
  • Strong thematic focus on Biotechnology, Therapeutics, Health Care.

Stage Focus

  • Series D (26%)
  • Series C (21%)
  • Post Ipo Equity (16%)
  • Series F (11%)
  • Series E (11%)
  • Series Unknown (5%)
  • Private Equity (5%)
  • Series B (5%)

Country Focus

  • Germany (95%)
  • Switzerland (5%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Health Care
  • Pharmaceutical
  • Medical
  • Biopharma
  • Health Diagnostics
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does dievini Hopp Biotech Holding frequently co-invest with?

Co-Investments: 1
Wellington Partners
Europe, Bayern, Germany, Munich
Co-Investments: 5
Baillie Gifford
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 1
Bill & Melinda Gates Foundation
North America, New York, United States, New York
Co-Investments: 1
Sigma Group
North America, New Jersey, United States, Saddle River
Co-Investments: 1
Co-Investments: 1
Northview LifeSciences
North America, British Columbia, Canada, Vancouver
Co-Investments: 1
AI
Europe, Bayern, Germany, Munich
Co-Investments: 5
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 1
Redmile Group
North America, California, United States, San Francisco
Co-Investments: 1

What are some of recent deals done by dievini Hopp Biotech Holding?

Novaliq

Heidelberg, Baden-Wurttemberg, Germany

Novaliq is a pharmaceutical company for the development and commercialization of first- and best-in-class ocular therapeutics.

BiotechnologyHealth CarePharmaceutical
Series UnknownApr 12, 2022
Amount Raised: $15,048,306
Heidelberg Pharma

Ladenburg, Baden-Wurttemberg, Germany

Heidelberg Pharma GmbH is a company providing pre-clinical drug discovery and development services.

BiotechnologyHealth CarePharmaceutical
Post Ipo EquityApr 27, 2020
Amount Raised: $15,587,705
immatics biotechnologies

Tübingen, Baden-Wurttemberg, Germany

Immatics is a biopharmaceutical company focused on the development of immunotherapeutic substances for cancer therapy.

BiotechnologyMedicalTherapeutics
Post Ipo EquityMar 17, 2020
Amount Raised: $104,000,000
Heidelberg Pharma

Ladenburg, Baden-Wurttemberg, Germany

Heidelberg Pharma GmbH is a company providing pre-clinical drug discovery and development services.

BiotechnologyHealth CarePharmaceutical
Post Ipo EquityJan 22, 2020
Amount Raised: $16,643,717
Novaliq

Heidelberg, Baden-Wurttemberg, Germany

Novaliq is a pharmaceutical company for the development and commercialization of first- and best-in-class ocular therapeutics.

BiotechnologyHealth CarePharmaceutical
Series FOct 11, 2018
Amount Raised: $53,000,000
immatics biotechnologies

Tübingen, Baden-Wurttemberg, Germany

Immatics is a biopharmaceutical company focused on the development of immunotherapeutic substances for cancer therapy.

BiotechnologyMedicalTherapeutics
Series EOct 4, 2017
Amount Raised: $58,000,000
Molecular Health

Heidelberg, Baden-Wurttemberg, Germany

Molecular Health offers software solutions for evidence-based healthcare decision support and smarter drug development.

BiotechnologyHealth CareHealth DiagnosticsInformation TechnologyMedical
Private EquityNov 16, 2015
Amount Raised: $26,712,712
CureVac

Tübingen, Baden-Wurttemberg, Germany

CureVac is a clinical-stage biopharmaceutical company that provides prophylactic and therapeutic application of messenger RNA.

BiopharmaBiotechnologyTherapeutics
Series FNov 3, 2015
Amount Raised: $107,974,788
immatics biotechnologies

Tübingen, Baden-Wurttemberg, Germany

Immatics is a biopharmaceutical company focused on the development of immunotherapeutic substances for cancer therapy.

BiotechnologyMedicalTherapeutics
Series DJul 16, 2014
Amount Raised: $29,756,551
AC Immune

Lausanne, Vaud, Switzerland

AC Immune is a biopharmaceutical company focused on neurodegenerative diseases with three product candidates in clinical trials

BiotechnologyPharmaceuticalTherapeutics
Series DJan 9, 2014
Amount Raised: $22,033,469

Find More Investors Like dievini Hopp Biotech Holding

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

dievini Hopp Biotech Holding | Pipeseed